Yong Fang

Construction of a tumor cell-targeting non-viral gene delivery vector with polyethylenimine modified with RGD sequence-containing peptide

H. Xing, H. Pan, Yong Fang, 2013, Oncology letters.

CT-guided percutaneous minimally invasive radiofrequency ablation for the relief of cancer related pain from metastatic non-small cell lung cancer patients: a retrospective study.

H. Pan, Yong Fang, Xiaoyun Zhou, 2020, Annals of palliative medicine.

Multiple Primary Malignant Tumors - A Clinical Analysis of 15,321 Patients with Malignancies at a Single Center in China

H. Pan, Yong Fang, W. Han, 2018, Journal of Cancer.

Camrelizumab Plus Apatinib in Treatment-Naive Patients With Advanced Nonsquamous NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 2 Trial

Jianxing He, R. Guo, Yong Fang, 2022, JTO clinical and research reports.

Apatinib plus gefitinib as first-line treatment in advanced EGFR-mutant non-small cell lung cancer: the phase III ACTIVE study (CTONG1706).

Chengping Hu, Gang Wu, Yong Fang, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Camrelizumab Plus Apatinib in Extensive-Stage Small-Cell Lung Cancer (PASSION): A Multicenter, Two-Stage, Phase 2 Trial.

Lifeng Wang, Yong Fang, Haihua Yang, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Ying Cheng, Wei Shi, Yunpeng Liu, 2022, The Lancet. Oncology.

Identification of key tumorigenesis‑related genes and their microRNAs in colon cancer.

Xiaoping Zhou, H. Pan, Yong Fang, 2018, Oncology reports.

Quantitation of cell-free DNA in blood is a potential screening and diagnostic maker of breast cancer: a meta-analysis

H. Pan, Yong Fang, W. Han, 2017, Oncotarget.

Nec-1 Enhances Shikonin-Induced Apoptosis in Leukemia Cells by Inhibition of RIP-1 and ERK1/2

H. Pan, Yong Fang, W. Han, 2012, International journal of molecular sciences.

A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors

Fan Mo, Rongchang Chen, H. Pan, 2020, Clinical Cancer Research.